Jazz Pharmaceuticals plc Form SCHEDULE 13G: Beneficial ownership report (passive)
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-06: Form SCHEDULE 13G; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X02/primary_doc.xml.
- 2026-04-30: Form SCHEDULE 13G; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X02/primary_doc.xml.
- 2026-03-27: Form SCHEDULE 13G/A; Description Beneficial ownership report (passive); Document xslSCHEDULE_13G_X02/primary_doc.xml.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-06 | SCHEDULE 13G | Beneficial ownership report (passive) | xslSCHEDULE_13G_X02/primary_doc.xml | |
| 2026-04-30 | SCHEDULE 13G | Beneficial ownership report (passive) | xslSCHEDULE_13G_X02/primary_doc.xml | |
| 2026-03-27 | SCHEDULE 13G/A | Beneficial ownership report (passive) | xslSCHEDULE_13G_X02/primary_doc.xml |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |